Trastuzumab Terminated Phase 2 Trials for Cancer of the Ovary Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00189579Addition of Herceptin to a Carboplatin-Paclitaxel Regimen in Patients With Ovarian Cancer